Latham & Watkins Helps Pharma Companies Collaborate
South San Francisco-based Alios Biopharma Inc. turned to Latham & Watkins LLP for its agreement to collaborate with Vertex Pharmaceuticals. Massachusetts-based Vertex Pharmaceuticals will pay $60 million to Alios to develop and commercialize a treatment for chromic hepatitis C. Alios could receive $1.47 billion in payments for reaching certain milestones. The Latham &...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In